Suppr
超能文献

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

作者信息

MCINTYRE N, HOLDSWORTH C D, TURNER D S

出版信息

Lancet. 1964 Jul 4;2(7349):20-1. doi: 10.1016/s0140-6736(64)90011-x.

DOI:10.1016/s0140-6736(64)90011-x

PMID:14149200

Abstract

摘要

相似文献

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

Lancet. 1964 Jul 4;2(7349):20-1. doi: 10.1016/s0140-6736(64)90011-x.

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

Lancet. 1964 Oct 17;2(7364):865. doi: 10.1016/s0140-6736(64)90724-x.

INTERPRETATION OF THE INTRAVENOUS GLUCOSE TEST.

Lancet. 1965 Feb 27;1(7383):462-3. doi: 10.1016/s0140-6736(65)91592-8.

INSULIN RESPONSE TO GLUCOSE LOADING IN ACROMEGALY.

Lancet. 1964 Oct 10;2(7363):769-71. doi: 10.1016/s0140-6736(64)90556-2.

[Glucose and insulin level following oral, intrajejunal and intravenous glucose administration in patients undergoing gastric surgery].

Rev Clin Esp. 1976 Mar 15;140(5):435-43.

Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes.

Acta Endocrinol Suppl (Copenh). 1979;224:5-32.

COMPARISON OF STANDARD ORAL GLUCOSE-TOLERANCE TEST AND RAPID INTRAVENOUS GLUCOSE-TOLERANCE TEST IN NORMAL PREGNANCY.

Obstet Gynecol. 1964 Oct;24:580-3.

Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects.

PLoS One. 2015 Nov 23;10(11):e0143405. doi: 10.1371/journal.pone.0143405. eCollection 2015.

CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY.

Lancet. 1965 Feb 6;1(7380):286-9. doi: 10.1016/s0140-6736(65)91026-3.

More severe impairment of oral than intravenous glucose tolerance in rats after eating a high fat diet.

J Nutr. 1985 Nov;115(11):1471-6. doi: 10.1093/jn/115.11.1471.

引用本文的文献

New Perspectives in Modulating the Entero-Insular Axis in Pediatric Obesity.

Int J Mol Sci. 2025 Jun 26;26(13):6143. doi: 10.3390/ijms26136143.

The pancreatic β-cell incretin response is modulated by mitochondrial transaminase GPT2.

Res Sq. 2025 Jun 30:rs.3.rs-6950998. doi: 10.21203/rs.3.rs-6950998/v1.

GLP-1R in diabetes mellitus: from basic discovery to therapeutics development.

Front Pharmacol. 2025 May 30;16:1610512. doi: 10.3389/fphar.2025.1610512. eCollection 2025.

Evolving Role of GLP-1 Therapies in Liver Disease.

Curr Gastroenterol Rep. 2025 Jun 6;27(1):36. doi: 10.1007/s11894-025-00988-2.

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.

Diabetes Metab J. 2025 May;49(3):333-347. doi: 10.4093/dmj.2025.0106. Epub 2025 May 1.

Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity.

Integr Pharm Res Pract. 2025 Apr 6;14:59-72. doi: 10.2147/IPRP.S503501. eCollection 2025.

The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis.

Front Pharmacol. 2025 Mar 25;16:1528295. doi: 10.3389/fphar.2025.1528295. eCollection 2025.

Glucose-dependent insulinotropic polypeptide (GIP).

Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.

Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.

Endocr Rev. 2025 Jul 15;46(4):479-500. doi: 10.1210/endrev/bnaf006.

Betagenin ameliorates diabetes by inducing insulin secretion and β-cell proliferation.

J Biol Chem. 2025 Feb;301(2):108202. doi: 10.1016/j.jbc.2025.108202. Epub 2025 Jan 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译